Targeting JAKs in SLE would be a logical therapeutic option which can be studied further starting with trials to determine the safety, pharmacodynamics and efficacy of these drugs in SLE

Targeting JAKs in SLE would be a logical therapeutic option which can be studied further starting with trials to determine…

The trial has had the opportunity to open centres to recruitment at an instant pace, with 22 centres available to recruitment in the first week and 65 centres available to recruitment within 4 a few months

The trial has had the opportunity to open centres to recruitment at an instant pace, with 22 centres available to…

Our current data claim that instead of donor vaccination, immunogenic peptides enable you to selectively broaden Id-specific T cells ex lover vivo to create educated donor lymphocyte infusions (DLI)

Our current data claim that instead of donor vaccination, immunogenic peptides enable you to selectively broaden Id-specific T cells ex…